Profusa Receives Nasdaq Delisting Notice for Failing Bid Price, Market Value Rules
PFSA is trading near its 52-week low of $0.82 (15% above the low) on light trading volume (0.1× avg).
Summary
Profusa, Inc. has received a formal delisting notice from Nasdaq on March 11, 2026, for failing to meet both the $50 million market value of listed securities requirement and the $1.00 minimum bid price rule. This critical development follows the company's decision on February 27, 2026, to withdraw its S-1 registration statement for a public offering, indicating persistent financial difficulties and challenges in capital formation. The delisting notice, based on an 8-K filing, poses a significant threat to the company's public trading status and liquidity, especially given its current market capitalization. Profusa intends to appeal the decision to a Hearings Panel by March 20, 2026; the outcome of this appeal will be the next crucial event for investors.
At the time of this announcement, PFSA was trading at $0.94 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.3M. The 52-week trading range was $0.82 to $975.00. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Wiseek News.